EUVIMEDOpdag EUVIMED
Übersichtsarbeit

The Use of Omics Sciences in Allergic Diseases From Bench to Bedside: An EAACI Position Paper

Chiara Tontini iD, Urszula Radzikowska iD, Carlos J Aranda iD, Marlena Tynecka iD, María Isabel Delgado Dolset iD, Andrzej Eljaszewicz iD, José Antonio Cornejo-García iD, Alma Villaseñor iD, Adriana Ariza iD, Nuria Contreras iD, Juan C López-Rodríguez iD, Dilara Karaguzel iD and 11 more

Allergy · 2025

DOI: 10.1111/all.16638 ↗

At a glance

Übersichtsarbeit in Allergy, 2025. Written by Chiara Tontini and 22 co-authors. Institution: Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, Lydia Becker Institute of Immunology and Inflammati…. Major MEDLINE topics: Hypersensitivity, Metabolomics, Genomics. Cited 11 times so far (Crossref); 165 references. Funded by: European Academy of Allergy and Clinical Immunology (EAACI) under the EAACI Task Force "The Use of Omics Sciences in Asthma and Allergy Clinical Practice", European Academy of Allergy and Clinical Immunology.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Omics have revolutionized our understanding of allergic diseases, with increasingly more studies adopting techniques like genomics, proteomics, and metabolomics over the years. Integrating high‐dimensional omics data with clinical features can enable more precise disease classification and biomarker identification, leading to improved disease management and the development of novel therapies. However, translating these discoveries into clinical practice remains a challenge. In this European Academy of Allergy and Clinical Immunology (EAACI) Position Paper, the Task Force (TF) “The Use of Omics Sciences in Asthma and Allergy Clinical Practice” performed a broad review of recent papers where omics technologies were used in the context of clinical studies and provided a summary of relevant findings in the field of asthma, atopic dermatitis, allergic rhinitis, food allergy and drug hypersensitivity reactions. Particular attention was dedicated to studies investigating overlapping diseases/co‐morbidities, revealing unique and shared signatures that could guide future therapeutic and research efforts. Furthermore, current hurdles in translating findings from bench to bedside were explained, and possible solutions were offered. With this position paper, the TF aims to assist researchers and clinicians by providing an overview of the investigations performed to date, highlighting gaps in research, limitations, and avenues for further exploration in clinical practice.

Subjects

MeSH terms (MEDLINE)

HypersensitivityMetabolomicsGenomicsHumansProteomicsBiomarkersTranslational Research, Biomedical

Author keywords

allergic rhinitisallergyasthmaatopic dermatitisdrug allergyfood allergyomicsprecision medicine

Substances

Biomarkers

Authors and institutions

  • Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK.
  • Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
  • Allergy Unit and Research Group, Hospital Regional Universitario de Málaga and IBIMA-Plataforma BIONAND, RICORS Inflammatory Diseases, Málaga, Spain.
  • Centre of Regenerative Medicine, Medical University of Bialystok, Bialystok, Poland.
  • Centro de Metabolómica y Bioanálisis (CEMBIO), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Spain.
  • Departamento de Ciencias Médicas Básicas, Facultad de Medicina, Instituto de Medicina Molecular Aplicada-Nemesio Díez (IMMA-ND), Universidad San Pablo-CEU, CEU Universities, Madrid, Spain.

ORCID profiles: Chiara Tontini, Urszula Radzikowska, Carlos J Aranda, Marlena Tynecka, María Isabel Delgado Dolset, Andrzej Eljaszewicz, José Antonio Cornejo-García, Alma Villaseñor, Adriana Ariza, Nuria Contreras, Juan C López-Rodríguez, Dilara Karaguzel, Daniel Lozano-Ojalvo, Riccardo Castagnoli, Ibon Eguiluz-Gracia, Milena Sokolowska, Cristobalina Mayorga, Christiane Hilger, Charlotte G Mortz, Oliver Pfaar, Domingo Barber, Maria M Escribese, Cagatay Karaaslan

Funding

  • European Academy of Allergy and Clinical Immunology (EAACI) under the EAACI Task Force "The Use of Omics Sciences in Asthma and Allergy Clinical Practice"
  • European Academy of Allergy and Clinical Immunology

Cite

APA

Tontini, C., Radzikowska, U., Aranda, C. J., Tynecka, M., Dolset, M. I. D., Eljaszewicz, A., Cornejo-García, J. A., Villaseñor, A., Ariza, A., Contreras, N., López-Rodríguez, J. C., Karaguzel, D., Lozano-Ojalvo, D., Castagnoli, R., Eguiluz-Gracia, I., Sokolowska, M., Mayorga, C., Hilger, C., Mortz, C. G., …, & Karaaslan, C. (2025). The Use of Omics Sciences in Allergic Diseases From Bench to Bedside: An EAACI Position Paper. Allergy. https://doi.org/10.1111/all.16638

Vancouver

Tontini C, Radzikowska U, Aranda CJ, Tynecka M, Dolset MID, Eljaszewicz A, et al. The Use of Omics Sciences in Allergic Diseases From Bench to Bedside: An EAACI Position Paper. Allergy. 2025. doi:10.1111/all.16638

BibTeX
@article{Tontini2025,
  author = {Tontini, Chiara and Radzikowska, Urszula and Aranda, Carlos J and Tynecka, Marlena and Dolset, María Isabel Delgado and Eljaszewicz, Andrzej and Cornejo-García, José Antonio and Villaseñor, Alma and Ariza, Adriana and Contreras, Nuria and López-Rodríguez, Juan C and Karaguzel, Dilara and Lozano-Ojalvo, Daniel and Castagnoli, Riccardo and Eguiluz-Gracia, Ibon and Sokolowska, Milena and Mayorga, Cristobalina and Hilger, Christiane and Mortz, Charlotte G and Pfaar, Oliver and Barber, Domingo and Escribese, Maria M and Karaaslan, Cagatay},
  title = {The Use of Omics Sciences in Allergic Diseases From Bench to Bedside: An EAACI Position Paper},
  journal = {Allergy},
  year = {2025},
  doi = {10.1111/all.16638}
}
Start for free →